CASI - CASI Pharmaceuticals Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results - Earnings Call Transcript
CASI Pharmaceuticals, Inc. (CASI) Q1 2022 Earnings Conference Call May 12, 2022, 08:00 AM ET Company Participants Wei-Wu He - Chairman and Chief Executive Officer Wei Zhang - President Larry Zhang - President Alexander Zukiwski - Executive Vice President and Chief Medical Officer James Goldschmidt - Chief Business Development Officer Conference Call Participants Justin Zelin - BTIG Sean Lee - HC Wainwright Trevor Allred - Oppenheimer Presentation Operator Good morning everyone and welcome to the CASI Pharmaceuticals First Quarter 2022 Business Update and Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please also note today’s event is being recorded. At this time, I’d like to turn the floor over to Wei Zhang, Vice President of CASI Pharmaceuticals. Please go ahead. Wei Zhang Thank you, Jimmy. Good morning and welcome to CASI’s
For further details see:
CASI Pharmaceuticals, Inc.'s (CASI) CEO Wei-Wu He on Q1 2022 Results - Earnings Call Transcript